CEUS与MRI门静脉期表现不一致:肝内胆管癌的有价值预测指标?
回顾性分析99例(73例确诊ICC、26例其他诊断)门静脉期CEUS与MRI强化表现不一致的病例,发现67/73(92%)ICC存在这种独特不一致,MRI与CEUS门静脉期表现差异有统计学意义(p < 0.0001),动脉期强化差异无统计学意义(p > 0.05);其他诊断(淋巴瘤7例、硬化性血管瘤6例、HCC 4例、转移瘤2例等)亦偶见该不一致。
要点
- CEUS显示快速明显廓清而MRI显示渐进或持续强化,这种门静脉期不一致在ICC中占67/73(92%)。
- 该不一致在淋巴瘤(n=7)、硬化性血管瘤(n=6)、HCC(n=4)、转移瘤(n=2)等其他肝脏病变中亦罕见出现。
- 作者认为在高危患者中应将此不一致与其他LR-M特征一同考虑。
核心结论
- ICC在统计学显著数量的病例中表现为这种跨模态强化不一致,在高危患者中应与其他LR-M特征一同考虑。
- 该不一致也罕见地见于其他肝脏病变。
研究设计与样本
- 回顾性研究,共纳入99例患者,其中73例为确诊ICC,26例为其他诊断。
- 病例来自本院CEUS科室及病理记录,时间跨度为十年。
- 所有患者均比较CEUS与MRI的强化特征。
关键影像表现/征象
- 门静脉期CEUS显示快速明显廓清,而MRI显示渐进或持续强化,构成独特的不一致。
- 动脉期强化在CEUS与MRI之间差异无统计学意义(p > 0.05)。
- 其他出现该不一致的诊断包括淋巴瘤(n=7)、硬化性血管瘤(n=6)、HCC(n=4)、转移瘤(n=2)及其他罕见病变。
诊断标准与关键数值
- 独特不一致定义为门静脉期CEUS显示快速明显廓清而MRI显示渐进或持续强化。
- 该不一致在73例ICC中识别出67例(92%),MRI与CEUS门静脉期表现差异有统计学意义(p < 0.0001)。
- 动脉期强化在CEUS与MRI之间差异无统计学意义(p > 0.05)。
临床应用与阅片要点
- 作者认为在高危患者中应将门静脉期CEUS与MRI表现不一致与其他LR-M特征一同考虑以提示ICC。
- 阅片时需注意该不一致也可见于淋巴瘤、硬化性血管瘤、HCC、转移瘤等其他肝脏病变。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: We have long noted unique portal venous phase (PVP) imaging discordance of focal liver masses between CEUS, showing rapid marked washout, and MRI, showing progressive or sustained enhancement. We postulate association of this unique discordance with intrahepatic cholangiocarcinoma (ICC) and causal relationship to different contrast agent behavior. We investigate this unique discordance, propose its clinical significance for ICC diagnosis, and confirm further histologic associations.
METHODS: Cases were collected within our CEUS department and from pathology records over a ten-year interval. This retrospective review includes 99 patients, 73 with confirmed ICC and 26 other diagnoses, showing unique PVP discordance. The CEUS and MRI enhancement characteristics were compared for all patients.
RESULTS: Unique discordance is identified in 67/73 (92%) ICC and difference between the PVP appearance on MRI and CEUS is statistically significant (p < 0.0001). Arterial phase enhancement did not show statistically significant difference between CEUS and MRI, p > 0.05. Other diagnoses showing unique discordance include especially lymphoma (n = 7), sclerosed hemangioma (n = 6), HCC (n = 4), metastases (n = 2), and other rare entities.
CONCLUSION: ICC shows this discrepant intermodality enhancement pattern in a statistically significant number of cases and should be considered along with other LR-M features in at-risk patients. Discordance is also rarely seen in a number of other liver lesions.
引用
- Wilson SR, Burrowes DP, Merrill C, et al. Unique portal venous phase imaging discordance between CEUS and MRI: a valuable predictor of intrahepatic cholangiocarcinoma? Abdom Radiol (NY). 2023. PMID: 37804423. doi:10.1007/s00261-023-04031-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。